Sándor Nardai1, MD, PhD; Eszter Végh1,2, MD, PhD; Viktor Óriás1, MD; Balázs Nemes1, MD, PhD; Júlia Tóth2, MD; Artúr Hüttl1, MD; Kálmán Hüttl1, MD, DSc; Babunashvili Avantadil3, MD, PhD; Olivier Francois Bertrand4, MD, PhD; Béla Merkely1, MD, DSc; Zoltán Ruzsa1,2, MD, PhD
1. Semmelweis University, Heart and Vascular Center, Budapest, Hungary; 2. Bács-Kiskun County Hospital, Invasive Cardiology Department, Teaching Hospital of the Szent-Györgyi Albert Medical University, Kecskemét, Hungary; 3. Department of Cardiovascular Surgery, Center for Endosurgery and Lithotripsy, Moscow, Russian Federation; 4. University Laval, Cardiology Department, Quebec, Canada
Introduction
Increased procedural safety and improved patient comfort are the two key advantages of the transradial approach (TRA) over traditional femoral access (FA)1, which has led to its growing popularity2,3. While the favourable safety profile of the TRA is reflected in the high-level recommendations for its use in cardiology, the relatively high rate of radial artery occlusions (RAO) remains an important concern4. The distal transradial approach (DTRA) was developed to address the issue of RAO without compromising efficacy or patient comfort.
Encouraged by the initial data published on the DTRA for percutaneous coronary interventions (PCI)5, we decided ...